Hansin Bio-Infra India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 07-07-2024
- Paid Up Capital ₹ 5.00 M
as on 07-07-2024
- Company Age 11 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 15.10 M
as on 07-07-2024
- Revenue 70.55%
(FY 2023)
- Profit -6.02%
(FY 2023)
- Ebitda -1.90%
(FY 2023)
- Net Worth 2.06%
(FY 2023)
- Total Assets -1.80%
(FY 2023)
About Hansin Bio-Infra India
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹1.51 Cr.
Arun Singh and Arpita Singh serve as directors at the Company.
- CIN/LLPIN
U45400DL2012PTC244676
- Company No.
244676
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Nov 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Hansin Bio-Infra India Private Limited offer?
Hansin Bio-Infra India Private Limited offers a wide range of products and services, including Prefabricated Houses & Structures, Prefabricated Structures, Fresh Flowers, Plants & Trees, Flowering Plant, Garden Equipment, Hydroponic Systems, Polyhouse, Greenhouse, Farming Tools, Equipment & Machines, Agro Shade Net.
Who are the key members and board of directors at Hansin Bio-Infra India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Singh  | Director | 08-Nov-2012 | Current |
| Arpita Singh | Director | 08-Nov-2012 | Current |
Financial Performance and Corporate Structure Insights of Hansin Bio-Infra India.
Hansin Bio-Infra India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 70.55% increase. The company also saw a slight decrease in profitability, with a 6.02% decrease in profit. The company's net worth moved up by a moderate rise of 2.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hansin Bio-Infra India?
In 2023, Hansin Bio-Infra India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Dec 2022 | ₹0.95 M | Open |
Others Creation Date: 06 May 2020 | ₹0.95 M | Open |
Bank Of Baroda Creation Date: 01 Feb 2016 | ₹3.70 M | Open |
How Many Employees Work at Hansin Bio-Infra India?
Hansin Bio-Infra India has a workforce of 0 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Mar 05, 2014, Hansin Bio-Infra India has raised a total of ₹ 9.8 M, with the most recent deal valued at ₹ 4.9 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
